Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention [Original Articles] - Lee, C. R., Sriramoju, V. B., Cervantes, A., Howell, L. A., Varunok, N., Madan, S., Hamrick, K., Polasek, M. J., Lee, J. A., Clarke, M., Cicci, J. D., Weck, K. E., Stouffer, G. A. (American Heart Association (AHA), 2018)
6224588
Keywords: WW-YZ